Dr. Lauren A. George

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as an Elite provider by MediFind in the treatment of Gastrointestinal Fistula. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass.

Eric Goldberg is a Gastroenterologist in Baltimore, Maryland. Dr. Goldberg is rated as a Distinguished provider by MediFind in the treatment of Gastrointestinal Fistula. His top areas of expertise are Crohn's Disease, Bile Duct Obstruction, Bile Duct Stricture, Endoscopy, and Colonoscopy.

Gastroenterologist Florin Selaru has faculty appointments to the Division of Gastroenterology and Hepatology; the Johns Hopkins Kimmel Cancer Center; and the Department of Biomedical Engineering and the Institute of NanoBioTechnology at The Johns Hopkins University. He is a clinical expert in inflammatory bowel disease (IBD) and serves as the director of the Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center at Johns Hopkins. Dr. Selaru earned his medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. He completed his internal medicine residency at University of Maryland Medical Center in Baltimore and completed his fellowship training in gastroenterology and hepatology at the Johns Hopkins University School of Medicine. Dr. Selaru’s research focuses on the intersection of clinical medicine, engineering and biology. His research expertise is in the utilization of bioengineering tools to answer clinically relevant questions and to translate findings for use in the clinical setting. He established and leads the Selaru lab, a National Institutes of Health-funded laboratory at Johns Hopkins that focuses on inflammation, fibrosis and cancer. The Selaru lab specializes in drug and device development for inflammatory and malignant conditions, as well as tissue regeneration solutions. Some specific projects include drug development for fibrosis in the gastrointestinal tract, microrobot development for oral drug delivery, tissue engineering for fistulas and other tissue defects in IBD, and novel drug targeting approaches for inflammation and cancer. Dr. Selaru’s overarching goal is to deliver medical products and technologies to patients with IBD and cancer. Dr. Selaru is rated as an Advanced provider by MediFind in the treatment of Gastrointestinal Fistula. His top areas of expertise are Viral Gastroenteritis, Cholangiocarcinoma (Bile Duct Cancer), Crohn's Disease, Gastrointestinal Fistula, and Endoscopy.